Key Takeaways
- • Clayton Dubilier & Rice and McKesson Corp. agreed to acquire Option Care Health for $5.8 billion, taking the largest U.S. independent provider of home and alternate-site infusion services private.
- • The transaction marks a significant consolidation move in the home infusion services sector, combining PE capital with healthcare distribution and services expertise.
- • Four advisory firms were engaged to structure and execute the take-private transaction.
Summary
Clayton Dubilier & Rice, a prominent private equity firm, and McKesson Corp., a major healthcare company, announced a definitive agreement on October 6, 2026, to acquire Option Care Health for $5.8 billion. The transaction will take Option Care Health private, removing the largest independent U.S. provider of home and alternate-site infusion services from public markets.
The deal brings together McKesson's scale and healthcare distribution capabilities with Clayton Dubilier & Rice's operational and financial expertise, positioning the combined entity to capture growth opportunities in the home infusion market. This sector has experienced increased demand as healthcare systems shift patient care away from traditional hospital settings toward home-based and alternate-site care models.
Four professional advisory firms were engaged to advise on the transaction structure and execution, though specific roles and advisors were not detailed in the announcement. The combination reflects a strategic bet on consolidation in home healthcare services and positions both sponsors to capture synergies across distribution, clinical operations, and reimbursement management.
The deal brings together McKesson's scale and healthcare distribution capabilities with Clayton Dubilier & Rice's operational and financial expertise, positioning the combined entity to capture growth opportunities in the home infusion market. This sector has experienced increased demand as healthcare systems shift patient care away from traditional hospital settings toward home-based and alternate-site care models.
Four professional advisory firms were engaged to advise on the transaction structure and execution, though specific roles and advisors were not detailed in the announcement. The combination reflects a strategic bet on consolidation in home healthcare services and positions both sponsors to capture synergies across distribution, clinical operations, and reimbursement management.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.